NeoGenomics (NEO) Tops Q3 EPS by 3c, Beats on Revenues; Lifts FY18 EPS/Revenue Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to NeoGenomics (NEO) Tops Q3 EPS by 3c, Beats on Revenues; Lifts FY18 EPS/Revenue Outlook Above Consensus

Neogenomics (NEO) PT Raised to $22 at Craig-Hallum

October 30, 2018 4:00 PM EDT

Craig-Hallum analyst Kevin Ellich raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 while maintaining a Buy rating.

Ellich cited "excellent" Q3 results while the Genoptix deal ads another layer of growth.

... More

Neogenomics (NEO) FV Raised to $20 at Janney Montgomery Scott

October 30, 2018 12:56 PM EDT

Janney Montgomery Scott analyst Paul Knight raised his fair value target on Neogenomics (NASDAQ: NEO) to $20.00 while maintaining a Buy rating following Q3 results.

... More